Week In Review: Shanghai Pharma Acquires Cardinal's China Drug Distribution Network For $1.2 Billion

Shanghai Pharma paid $1.2 billion to win the bidding war for Cardinal Health's China drug distribution operations. Cardinal was China's eighth-largest drug distribution company, with $3.5 billion in 2016 China revenues, while Shanghai Pharma is #3.